雷夫利珠单抗

化学数据

CAS号	1803171-55-2	货号	BCP46121
中文名	雷夫利珠单抗
英文名	Ravulizumab
中文别名
英文别名	ALXN-1210;ALXN1210;
分子式		分子量

用途

生物活性	Ravulizumab, a humanized monoclonal antibody that binds with high affinity to complement protein C5 and inhibits terminal complement activation, is being evaluated as a treatment for COVID-19-related severe pneumonia, acute lung injury, and acute respiratory distress syndrome in an ongoing phase 3 randomized controlled trial (ALXN1210-COV-305).

生物活性

Ravulizumab, a humanized monoclonal antibody that binds with high affinity to complement protein C5 and inhibits terminal complement activation, is being evaluated as a treatment for COVID-19-related severe pneumonia, acute lung injury, and acute respiratory distress syndrome in an ongoing phase 3 randomized controlled trial (ALXN1210-COV-305).

结构式

本页面部分数据来自于公开的网络资源,所以瀚香生物不能保证其准确性。

不同批次的产品详情请咨询我们的客服：

全国免费电话：400-099-8200

在线客服:

技术支持: orders@biochempartner.com

瀚香官网: www.biochempartner.com

瀚香生物（Biochempartner) 的所有产品和服务仅用于科学研究，禁止用于人体和治疗！